Antimicrobial therapy of community-acquired pneumonia. Review uri icon

Overview

abstract

  • Community-acquired pneumonia (CAP) is a common disorder that is potentially life-threatening, especially in older adults and patients with comorbid disease. Despite substantial progress in therapeutic options, CAP remains a primary cause of death from infectious disease in the United States. The mainstay of treatment for most patients is appropriate antimicrobial therapy This article reviews the principles for initial antimicrobial therapy, highlights some of the differences in approaches to antimicrobial drug selection in selected guidelines, and includes new recommendations for empiric and pathogen-directed therapy of CAP.

publication date

  • December 1, 2004

Research

keywords

  • Anti-Bacterial Agents
  • Pneumonia, Bacterial

Identity

PubMed Central ID

  • PMC7118969

Scopus Document Identifier

  • 8844265398

PubMed ID

  • 15555836

Additional Document Info

volume

  • 18

issue

  • 4